These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2458445)

  • 1. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
    Missale C; Memo M; Liberini P; Spano P
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1137-43. PubMed ID: 2458445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa.
    Missale C; Liberini P; Memo M; Carruba MO; Spano P
    Endocrinology; 1986 Nov; 119(5):2227-32. PubMed ID: 3533523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between serotonin and other regulators of aldosterone secretion in rat adrenal glomerulosa cells.
    Rocco S; Ambroz C; Aguilera G
    Endocrinology; 1990 Dec; 127(6):3103-10. PubMed ID: 2174345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-epsilon and calcium signaling.
    Chang HW; Wu VC; Huang CY; Huang HY; Chen YM; Chu TS; Wu KD; Hsieh BS
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E622-9. PubMed ID: 18171914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic regulation of aldosterone secretion. Biochemical mechanisms and pharmacology.
    Missale C; Lombardi C; Sigala S; Spano PF
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):93S-95S. PubMed ID: 2166536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of rat retinal dopamine receptors.
    Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of rat renal medulla dopamine-sensitive cyclic adenosine monophosphate generating system.
    Amenta F; Ricci A; Vega JA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):246-9. PubMed ID: 2158544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diltiazem on calcium metabolism in cultured bovine glomerulosa cells: relationships to the actions of angiotensin II and potassium.
    Kramer RE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):374-84. PubMed ID: 8331567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S
    J Pharmacol Exp Ther; 1989 Aug; 250(2):734-9. PubMed ID: 2474643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in the interaction of dopamine with angiotensin II on aldosterone secretion in isolated and cultured rat adrenal glomerulosa cells.
    Gallo-Payet N; Chouinard L; Balestre MN; Guillon G
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):11-23. PubMed ID: 1839152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP.
    Gambaryan S; Butt E; Tas P; Smolenski A; Allolio B; Walter U
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E423-33. PubMed ID: 16219670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of aldosterone production by angiotensin II is mediated by two guanine nucleotide regulatory proteins.
    Hausdorff WP; Sekura RD; Aguilera G; Catt KJ
    Endocrinology; 1987 Apr; 120(4):1668-78. PubMed ID: 2881777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the lipoxygenase pathway in angiotensin II-mediated aldosterone biosynthesis in human adrenal glomerulosa cells.
    Natarajan R; Stern N; Hsueh W; Do Y; Nadler J
    J Clin Endocrinol Metab; 1988 Sep; 67(3):584-91. PubMed ID: 2842363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine selectively inhibits aldosterone responses to angiotensin II in man.
    Carey RM; Drake CR
    J Hypertens Suppl; 1984 Dec; 2(3):S267-9. PubMed ID: 6100739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3',5'-monophosphate production in lactotroph cells.
    Audinot V; Rasolonjanahary R; Bertrand P; Priam M; Kordon C; Enjalbert A
    Endocrinology; 1991 Oct; 129(4):2231-9. PubMed ID: 1655395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.